ITRM20020625A1 - Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'. - Google Patents

Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.

Info

Publication number
ITRM20020625A1
ITRM20020625A1 IT000625A ITRM20020625A ITRM20020625A1 IT RM20020625 A1 ITRM20020625 A1 IT RM20020625A1 IT 000625 A IT000625 A IT 000625A IT RM20020625 A ITRM20020625 A IT RM20020625A IT RM20020625 A1 ITRM20020625 A1 IT RM20020625A1
Authority
IT
Italy
Prior art keywords
medications
guanidine
diabetic
derivatives
variously replaced
Prior art date
Application number
IT000625A
Other languages
English (en)
Italian (it)
Inventor
Maurizio Botta
Federico Corelli
Fabio Giannessi
Pompeo Pessotto
Emanuela Tassoni
Maria Ornella Tinti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT000625A priority Critical patent/ITRM20020625A1/it
Priority to BR0317397-6A priority patent/BR0317397A/pt
Priority to CNA2003801067329A priority patent/CN1729172A/zh
Priority to PL378416A priority patent/PL378416A1/pl
Priority to MXPA05006326A priority patent/MXPA05006326A/es
Priority to KR1020057011435A priority patent/KR20050089058A/ko
Priority to CA002506685A priority patent/CA2506685A1/en
Priority to PCT/IT2003/000792 priority patent/WO2004054967A1/en
Priority to EP03780657A priority patent/EP1575912A1/en
Priority to US10/537,269 priority patent/US7368605B2/en
Priority to JP2004560183A priority patent/JP2006509816A/ja
Priority to AU2003288534A priority patent/AU2003288534B2/en
Publication of ITRM20020625A1 publication Critical patent/ITRM20020625A1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IT000625A 2002-12-17 2002-12-17 Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'. ITRM20020625A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT000625A ITRM20020625A1 (it) 2002-12-17 2002-12-17 Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.
BR0317397-6A BR0317397A (pt) 2002-12-17 2003-12-01 Derivados de guanidina variadamente substituìdos e seu uso como medicamentos com atividade antidiabetes e/ou antiobesidade
CNA2003801067329A CN1729172A (zh) 2002-12-17 2003-12-01 胍的不同取代的衍生物及其作为具有抗糖尿病和/或抗肥胖活性的药物的用途
PL378416A PL378416A1 (pl) 2002-12-17 2003-12-01 Różnie podstawione pochodne guanidyny i ich zastosowanie jako leki o aktywności przeciwcukrzycowej i/lub przeciw otyłości
MXPA05006326A MXPA05006326A (es) 2002-12-17 2003-12-01 Derivados diversamente sustituidos de guanidina, y su uso como medicamentos con actividad anti-diabetes y/o anti-obesidad.
KR1020057011435A KR20050089058A (ko) 2002-12-17 2003-12-01 구아니딘의 다양하게 치환된 유도체, 및 당뇨병 치료및/또는 비만 억제 활성을 갖는 약제로서의 그의 용도
CA002506685A CA2506685A1 (en) 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
PCT/IT2003/000792 WO2004054967A1 (en) 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
EP03780657A EP1575912A1 (en) 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
US10/537,269 US7368605B2 (en) 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
JP2004560183A JP2006509816A (ja) 2002-12-17 2003-12-01 抗糖尿病性および/または肥満抑制性作用を有する、グアニジンの種々の置換誘導体、および医薬としてのその使用
AU2003288534A AU2003288534B2 (en) 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000625A ITRM20020625A1 (it) 2002-12-17 2002-12-17 Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.

Publications (1)

Publication Number Publication Date
ITRM20020625A1 true ITRM20020625A1 (it) 2004-06-18

Family

ID=32587901

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000625A ITRM20020625A1 (it) 2002-12-17 2002-12-17 Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.

Country Status (12)

Country Link
US (1) US7368605B2 (https=)
EP (1) EP1575912A1 (https=)
JP (1) JP2006509816A (https=)
KR (1) KR20050089058A (https=)
CN (1) CN1729172A (https=)
AU (1) AU2003288534B2 (https=)
BR (1) BR0317397A (https=)
CA (1) CA2506685A1 (https=)
IT (1) ITRM20020625A1 (https=)
MX (1) MXPA05006326A (https=)
PL (1) PL378416A1 (https=)
WO (1) WO2004054967A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873368B1 (fr) * 2004-07-26 2008-01-04 Merck Sante Soc Par Actions Si Derives de guanidine et leurs utilisations en therapeutique
CN101062906B (zh) * 2006-04-26 2012-02-08 中国人民解放军军事医学科学院毒物药物研究所 胍丁胺硫酸盐水合物及其用于戒毒,抗炎,降血糖以及胍丁胺代谢异常所致疾病的用途
CN101121677B (zh) * 2006-08-09 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 胍丁胺硫酸盐二水合物及其医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190639B (en) * 1983-12-12 1986-09-29 Gyogyszerkutato Intezet Kv,Hu Process for production of new aminoguanidin derivatives
IT1219846B (it) * 1988-02-24 1990-05-24 Consiglio Nazionale Ricerche Nuovi derivati guandinici ad attivita' ipotensia,composizione che li contengono e relativo procedimento di estrazione e purificazione da materiale botanico
JPH06510760A (ja) * 1991-08-27 1994-12-01 ジ・アップジョン・カンパニー 代謝障害および代謝の治療法
GB9511757D0 (en) * 1995-05-19 1995-08-02 Univ Strathclyde Agents for reducing weight
KR19990076594A (ko) * 1995-12-22 1999-10-15 피터 존 기딩스 Niddm 치료용 아미노구아니딘

Also Published As

Publication number Publication date
CN1729172A (zh) 2006-02-01
WO2004054967A1 (en) 2004-07-01
AU2003288534B2 (en) 2009-07-02
PL378416A1 (pl) 2006-04-03
US7368605B2 (en) 2008-05-06
JP2006509816A (ja) 2006-03-23
KR20050089058A (ko) 2005-09-07
EP1575912A1 (en) 2005-09-21
US20060069100A1 (en) 2006-03-30
BR0317397A (pt) 2005-11-16
AU2003288534A1 (en) 2004-07-09
CA2506685A1 (en) 2004-07-01
MXPA05006326A (es) 2005-08-26

Similar Documents

Publication Publication Date Title
ITRM20010464A0 (it) Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
ITRM20020411A0 (it) Derivati dello spirobifluorene, loro preparazione e loro uso.
NL1024643A1 (nl) Purineverbindingen en gebruik daarvan.
DE50312747D1 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
SI1368349T1 (sl) Ksantinski derivati, njihova priprava in njihova uporaba kot zdravila
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DE60234376D1 (de) 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimin-nucleoside und ihre verwendung
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
PT1500654E (pt) Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos
ITRM20020016A1 (it) Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
ITMI20021725A1 (it) Composizioni farmaceutiche ad attivita' antibiotica.
ATE396994T1 (de) 3-phenylpyridoindolderivate, ihre herstellung und verwendung
RU2002107079A (ru) Вещество, обладающее седативным действием
ITRM20020629A1 (it) Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
ATE484503T1 (de) 2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva
ITRM20020625A1 (it) Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.
NO20014692L (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
ITRM20020402A0 (it) Derivati fluoro-alchil-ciclopeptidi ad attivita' anti-integrine.
ITMI20000293A0 (it) Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica
ITRM20020119A1 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
DE50211897D1 (de) 3H-NAPHTHOÄ2,1-bÜ-PYRAN-DERIVATE SOWIE DEREN VERWENDUNG
ITRM20050611A1 (it) Derivati azanucleosidici ad attivita' antivirale.
ATE362916T1 (de) Substituierte propan- 1,3-diamin-derivate und ihre pharmazeutische verwendung